Capricor Therapeutics (CAPR) Balance Sheet: Assets & Liabilities

Capricor Therapeutics (CAPR) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Capricor Therapeutics reported total assets of $355.95M and total liabilities of $50.16M. Shareholders' equity was $305.79M, up 110.2% from $145.46M a year earlier. Total debt stood at $17.94M against $318.13M in cash and short-term investments, a net cash position of $300.18M. That puts debt-to-equity at 0.06, compared with 0.03 a year earlier.

Capricor Therapeutics Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Capricor Therapeutics, Inc. (CAPR) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017
Current Assets
Cash and Cash Equivalents	287.85	11.29	14.69	9.60	34.89	32.67	3.90	4.26	6.14
Short-Term Investments	30.28	140.23	24.79	31.82	0.00	0.00	5.99	3.00	7.98
Cash & Short-Term Investments	318.13	151.52	39.49	41.42	34.89	32.67	9.89	7.26	14.12
Accounts Receivable	0.06	10.37	10.37	0.55	0.39	0.06	0.09	0.20	0.34
Inventory	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Current Assets	4.75	1.50	1.00	0.92	1.16	0.96	0.57	1.01	1.24
Total Current Assets	322.94	163.39	50.86	42.89	36.44	33.68	10.54	8.47	15.71
Non-Current Assets
Property, Plant & Equipment (Net)	18.31	6.87	7.61	6.94	4.62	0.85	0.44	0.57	0.37
Intangible Assets	0.00	0.00	0.00	0.00	0.00	0.00	0.01	0.20	0.09
Other Non-Current Assets	14.70	0.22	0.27	0.27	0.28	0.09	0.12	0.15	0.10
Total Non-Current Assets	33.01	7.10	7.88	7.21	4.89	0.94	0.57	0.78	0.56
Total Assets	355.95	170.48	58.73	50.09	41.33	34.62	11.11	9.25	16.27
Current Liabilities
Accounts Payable	1.65	3.28	6.22	4.92	3.72	2.72	0.90	1.26	1.67
Short-Term Debt	3.62	0.83	0.75	0.68	0.42	0.25	0.00	0.00	0.00
Current Portion of Long-Term Debt	-	-	-	-	-	0.25	-	-	-
Accrued Liabilities	15.56	4.91	0.01	0.09	0.60	0.01	-	-	-
Deferred Revenue	12.00	12.00	24.27	17.98	0.00	0.00	0.00	0.00	0.00
Other Current Liabilities	18.56	4.91	0.00	0.09	0.00	0.00	0.00	0.00	0.00
Total Current Liabilities	35.84	21.03	31.27	23.59	4.13	2.97	0.90	1.26	1.67
Non-Current Liabilities
Long-Term Debt	14.32	3.99	1.49	1.88	2.45	0.07	3.38	3.38	3.38
Other Non-Current Liabilities	0.00	0.00	3.38	12.84	3.38	3.38	0.00	0.00	0.00
Total Non-Current Liabilities	14.32	3.99	4.86	14.72	5.83	3.45	3.38	3.38	3.38
Total Liabilities	50.16	25.02	36.13	38.31	9.96	6.42	4.27	4.63	5.05
Stockholders' Equity
Common Stock	0.06	0.05	0.03	0.03	0.02	0.02	0.01	0.00	0.03
Retained Earnings	-304.88	-199.83	-159.37	-137.08	-108.06	-88.04	-74.38	-66.74	-51.55
Accumulated Other Comprehensive Income	0.28	1.03	0.24	0.11	0.00	0.00	0.00	0.01	0.01
Additional Paid-in Capital	610.33	344.22	181.70	148.74	139.40	116.22	81.22	71.34	62.74
Shares Outstanding	57.37	45.58	31.15	25.24	24.19	-	-	-	-
Total Stockholders' Equity	305.79	145.46	22.60	11.79	31.37	28.20	6.84	4.62	11.23
Total Liabilities & Equity	355.95	170.48	58.73	50.09	41.33	34.62	11.11	9.25	16.27

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Capricor Therapeutics Balance Sheet

How much debt does Capricor Therapeutics have?

Capricor Therapeutics had total debt of $17.94M as of Dec 31, 2025, against $318.13M in cash and short-term investments. Its debt-to-equity ratio was 0.06. Total debt was $4.83M a year earlier.

What are Capricor Therapeutics's total assets?

Capricor Therapeutics reported total assets of $355.95M as of Dec 31, 2025, up 108.8% from $170.48M a year earlier. Total liabilities were $50.16M.

What is Capricor Therapeutics's shareholders' equity?

Capricor Therapeutics's shareholders' equity was $305.79M as of Dec 31, 2025, or about $5.33 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition